John T Henderson - Net Worth and Insider Trading
John T Henderson Net Worth
The estimated net worth of John T Henderson is at least $3 Million dollars as of 2024-12-01. John T Henderson is the Director of Cytokinetics Inc and owns about 32,153 shares of Cytokinetics Inc (CYTK) stock worth over $2 Million. John T Henderson is also the Director of Myriad Genetics Inc and owns about 66,403 shares of Myriad Genetics Inc (MYGN) stock worth over $1 Million. Details can be seen in John T Henderson's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that John T Henderson has not made any transactions after 2024-04-25 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of John T Henderson
John T Henderson Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, John T Henderson owns 3 companies in total, including Cytokinetics Inc (CYTK) , Myriad Genetics Inc (MYGN) , and Myrexis Inc (MYRX) .
Click here to see the complete history of John T Henderson’s form 4 insider trades.
Insider Ownership Summary of John T Henderson
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| CYTK | Cytokinetics Inc | 2024-04-25 | director |
| MYGN | Myriad Genetics Inc | 2019-11-07 | director |
| MYRX | Myrexis Inc | 2013-01-18 | director |
John T Henderson Latest Holdings Summary
John T Henderson currently owns a total of 2 stocks. Among these stocks, John T Henderson owns 32,153 shares of Cytokinetics Inc (CYTK) as of April 25, 2024, with a value of $2 Million and a weighting of 60.68%. John T Henderson also owns 66,403 shares of Myriad Genetics Inc (MYGN) as of November 7, 2019, with a value of $1 Million and a weighting of 39.32%.
Latest Holdings of John T Henderson
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| CYTK | Cytokinetics Inc | 2024-04-25 | 32,153 | 51.86 | 1,667,455 |
| MYGN | Myriad Genetics Inc | 2019-11-07 | 66,403 | 16.27 | 1,080,377 |
Holding Weightings of John T Henderson
John T Henderson Form 4 Trading Tracker
According to the SEC Form 4 filings, John T Henderson has made a total of 10 transactions in Cytokinetics Inc (CYTK) over the past 5 years, including 0 buys and 10 sells. The most-recent trade in Cytokinetics Inc is the sale of 10,562 shares on April 25, 2024, which brought John T Henderson around $681,672.
According to the SEC Form 4 filings, John T Henderson has made a total of 0 transactions in Myriad Genetics Inc (MYGN) over the past 5 years. The most-recent trade in Myriad Genetics Inc is the acquisition of 7,000 shares on November 7, 2019, which cost John T Henderson around $164,220.
Insider Trading History of John T Henderson
- 1
John T Henderson Trading Performance
GuruFocus tracks the stock performance after each of John T Henderson's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by John T Henderson is 6.06%. GuruFocus also compares John T Henderson's trading performance to market benchmark return within the same time period. The performance of stocks bought by John T Henderson within 3 months outperforms 2 times out of 5 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how John T Henderson's insider trading performs compared to the benchmark.
Performance of John T Henderson
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 4.6 | | | | | |
| Relative Return to S&P 500(%) | 1.65 | | | | | |
John T Henderson Ownership Network
John T Henderson Owned Company Details
What does Cytokinetics Inc do?
Who are the key executives at Cytokinetics Inc?
John T Henderson is the director of Cytokinetics Inc. Other key executives at Cytokinetics Inc include SVP Research & Early Dev Fady Ibraham Malik , EVP & Corp. Development & CBO Robert I Blum , and VP & Chief Accounting Officer Robert Wong .
Cytokinetics Inc (CYTK) Insider Trades Summary
Over the past 18 months, John T Henderson made 4 insider transaction in Cytokinetics Inc (CYTK) with a net sale of 23,020. Other recent insider transactions involving Cytokinetics Inc (CYTK) include a net sale of 331,000 shares made by Robert I Blum , a net sale of 205,949 shares made by Fady Ibraham Malik , and a net sale of 40,000 shares made by B Lynne Parshall .
In summary, during the past 3 months, insiders sold 90,420 shares of Cytokinetics Inc (CYTK) in total and bought 0 shares, with a net sale of 90,420 shares. During the past 18 months, 640,027 shares of Cytokinetics Inc (CYTK) were sold and 0 shares were bought by its insiders, resulting in a net sale of 640,027 shares.
Cytokinetics Inc (CYTK)'s detailed insider trading history can be found in Insider Trading Tracker table.
Cytokinetics Inc Insider Transactions
John T Henderson Mailing Address
Above is the net worth, insider trading, and ownership report for John T Henderson. You might contact John T Henderson via mailing address: 320 Wakara Way, Salt Lake City Ut 84108.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
